[go: up one dir, main page]

Uboldi et al., 1996 - Google Patents

Localization of apolipoprotein AI epitopes involved in the activation of lecithin: cholesterol acyltransferase

Uboldi et al., 1996

View PDF
Document ID
17275378342044536193
Author
Uboldi P
Spoladore M
Fantappie S
Marcovina S
Catapano A
Publication year
Publication venue
journal of Lipid Research

External Links

Snippet

Eight murine monoclonal antibodies (Mab) to apolipoprotein AI were characterized for their epitopes and for their ability to interfere with lecithin: cholesterol acyltransferase (LCAT) activation mediated by apo apoA-I using a synthetic substrate. Using overlapping synthetic …
Continue reading at www.jlr.org (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/775—Apolipopeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4208—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig

Similar Documents

Publication Publication Date Title
Marcel et al. Mapping of human apolipoprotein B antigenic determinants.
Weisgraber et al. Human apolipoprotein E. Determination of the heparin binding sites of apolipoprotein E3.
Calabresi et al. Apolipoprotein AI conformation in discoidal particles: evidence for alternate structures
Swenson et al. Mechanism of cholesteryl ester transfer protein inhibition by a neutralizing monoclonal antibody and mapping of the monoclonal antibody epitope
Hesler et al. Monoclonal antibodies to the Mr 74,000 cholesteryl ester transfer protein neutralize all of the cholesteryl ester and triglyceride transfer activities in human plasma.
Milne et al. Characterization of monoclonal antibodies against human low density lipoprotein.
Blanco-Vaca et al. Characterization of disulfide-linked heterodimers containing apolipoprotein D in human plasma lipoproteins.
US5168045A (en) Diagnostic systems and methods using polypeptide analogs of apolipoprotein e
US5473039A (en) Polypeptide analogs of apolipoprotein E, diagnostic systems and methods using the analogs
James et al. Characterization of a human high density lipoprotein-associated protein, NA1/NA2. Identity with SP-40, 40, an inhibitor of complement-mediated cytolysis.
Beisiegel et al. Apolipoprotein E-binding proteins isolated from dog and human liver.
UTERMANN et al. Apolipoprotein A‐IGiessen (Pro143→ Arg) A mutant that is defective in activating lecithin: cholesterol acyltransferase
Ohta et al. Studies on the in vivo and in vitro distribution of apolipoprotein A-IV in human plasma and lymph.
WO1997036927A1 (en) Amphipathic molecules as cholesterol and other lipid uptake inhibitors
Koike et al. Epitopes on β2-GPI recognized by anticardiolipin antibodies
US5814467A (en) APO AI polypeptides, diagnostic methods and systems for quantifying APO AI, and therapeutic methods
Luchoomun et al. Structural domain of apolipoprotein AI involved in its interaction with cells
Uboldi et al. Localization of apolipoprotein AI epitopes involved in the activation of lecithin: cholesterol acyltransferase
Ohnishi et al. Purification, characterization, and studies on biosynthesis of a 59-kDa bone sialic acid-containing protein (BSP) from rat mandible using a monoclonal antibody. Evidence that 59-kDa BSP may be the rat counterpart of human alpha 2-HS glycoprotein and is synthesized by both hepatocytes and osteoblasts
Benvenga et al. Localization of the thyroxine binding sites in apolipoprotein B-100 of human low density lipoproteins
Milne et al. Monoclonal antibodies distinguish between lipid-dependent and reversible conformational states of human apolipoprotein B
Keidar et al. Involvement of the macrophage low density lipoprotein receptor-binding domains in the uptake of oxidized low density lipoprotein.
Marcovina et al. Immunochemical characterization of six monoclonal antibodies to human apolipoprotein AI: epitope mapping and expression.
Imai et al. Natural autoantibody against apolipoprotein AI. Detection and characterization of the monoclonal antibody established from normal unimmunized BALB/c mice.
Barkia et al. Enzyme-linked immunosorbent assay for human proapolipoprotein AI using specific antibodies against synthetic peptide.